HHS Approval of Entities That Certify Medical Review Officers, 48683 [2022-17156]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 153 / Wednesday, August 10, 2022 / Notices
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice.
Subpart
M—Medical Review Officer (MRO),
Section 13.2 of the Mandatory
Guidelines, ‘‘How are nationally
recognized entities or subspecialty
boards that certify MROs approved?’’
states as follows: ‘‘All nationally
recognized entities or subspecialty
boards which seek approval by the
Secretary to certify physicians as MROs
for federal workplace drug testing
programs must submit their
qualifications, a sample examination,
and other necessary supporting
examination materials (e.g., answers,
previous examination statistics or other
background examination information, if
requested). Approval will be based on
an objective review of qualifications that
include a copy of the MRO applicant
application form, documentation that
the continuing education courses are
accredited by a professional
organization, and the delivery method
and content of the examination. Each
approved MRO certification entity must
resubmit their qualifications for
approval every two years. The Secretary
shall publish at least every two years a
notice in the Federal Register listing
those entities and subspecialty boards
that have been approved. This notice is
also available on the internet at https://
www.samhsa.gov/workplace/drugtesting.’’
HHS has completed its review of
entities that certify MROs, in
accordance with requests submitted by
such entities to HHS. The Assistant
Secretary for Mental Health and
Substance Use approves the following
MRO certifying entities that offer MRO
certification through examination:
This notice publishes a list of
the Department of Health and Human
Services (HHS) approved Medical
Review Officers certification entities.
The HHS Mandatory Guidelines for
Federal Workplace Drug Testing
Programs (Mandatory Guidelines),
effective on October 1, 2017, addresses
the role and qualifications of Medical
Review Officers (MROs) and HHS
approval of entities that certify MROs.
DATES: HHS approval is effective August
10, 2022.
FOR FURTHER INFORMATION CONTACT:
Sean J. Belouin, Pharm.D., CAPT,
United States Public Health Service,
Senior Science Policy Advisor,
Substance Abuse and Mental Health
American Association of Medical
Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC
27709, Phone: (919) 489–5407, Fax:
(919) 490–1010, Email: bbrandon@
aamro.com, Website: https://
www.aamro.com/.
Medical Review Officer Certification
Council (MROCC), 3231 S. Halsted St,
#167, Chicago, IL 60608, Phone: (847)
631–0599, Fax: (847) 483–1282,
Email: mrocc@mrocc.org, Website:
https://www.mrocc.org/.
MROPREP, 2108 N St, STE N,
Sacramento, CA 95816, Phone: (669)
299–5348, Email: support@
mroprep.com, Website: https://
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Institutional
Training Program (T32) Review.
Date: October 26, 2022.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, 6707 Democracy Blvd.,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3398, hayesj@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: August 4, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–17142 Filed 8–9–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
HHS Approval of Entities That Certify
Medical Review Officers
AGENCY:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Services Administration, 5600 Fishers
Lane, Rockville, Maryland 20857;
Telephone: (240) 276–2316; Email:
sean.belouin@samhsa.hhs.gov.
VerDate Sep<11>2014
17:26 Aug 09, 2022
Jkt 256001
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
48683
www.mroprep.com/courses/
mrocourse.
Miriam E. Delphin-Rittmon,
Assistant Secretary for Mental Health and
Substance Use.
[FR Doc. 2022–17156 Filed 8–9–22; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Citizenship and Immigration
Services
[OMB Control Number 1615–0113]
Agency Information Collection
Activities; Extension, Without Change,
of a Currently Approved Collection:
MyAppointment
U.S. Citizenship and
Immigration Services, Department of
Homeland Security.
ACTION: 30-Day notice.
AGENCY:
The Department of Homeland
Security (DHS), U.S. Citizenship and
Immigration Services (USCIS) will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and clearance in accordance
with the Paperwork Reduction Act of
1995. The purpose of this notice is to
allow an additional 30 days for public
comments.
DATES: Comments are encouraged and
will be accepted until September 9,
2022.
SUMMARY:
Written comments and/or
suggestions regarding the item(s)
contained in this notice, especially
regarding the estimated public burden
and associated response time, must be
submitted via the Federal eRulemaking
Portal website at https://
www.regulations.gov under e-Docket ID
number USCIS–2009–0024. All
submissions received must include the
OMB Control Number 1615–0113 in the
body of the letter, the agency name and
Docket ID USCIS–2009–0024.
FOR FURTHER INFORMATION CONTACT:
USCIS, Office of Policy and Strategy,
Regulatory Coordination Division,
Samantha Deshommes, Chief,
Telephone number (240) 721–3000
(This is not a toll-free number;
comments are not accepted via
telephone message.). Please note contact
information provided here is solely for
questions regarding this notice. It is not
for individual case status inquiries.
Applicants seeking information about
the status of their individual cases can
check Case Status Online, available at
ADDRESSES:
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 87, Number 153 (Wednesday, August 10, 2022)]
[Notices]
[Page 48683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
HHS Approval of Entities That Certify Medical Review Officers
AGENCY: Substance Abuse and Mental Health Services Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice publishes a list of the Department of Health and
Human Services (HHS) approved Medical Review Officers certification
entities. The HHS Mandatory Guidelines for Federal Workplace Drug
Testing Programs (Mandatory Guidelines), effective on October 1, 2017,
addresses the role and qualifications of Medical Review Officers (MROs)
and HHS approval of entities that certify MROs.
DATES: HHS approval is effective August 10, 2022.
FOR FURTHER INFORMATION CONTACT: Sean J. Belouin, Pharm.D., CAPT,
United States Public Health Service, Senior Science Policy Advisor,
Substance Abuse and Mental Health Services Administration, 5600 Fishers
Lane, Rockville, Maryland 20857; Telephone: (240) 276-2316; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Subpart M--Medical Review Officer (MRO),
Section 13.2 of the Mandatory Guidelines, ``How are nationally
recognized entities or subspecialty boards that certify MROs
approved?'' states as follows: ``All nationally recognized entities or
subspecialty boards which seek approval by the Secretary to certify
physicians as MROs for federal workplace drug testing programs must
submit their qualifications, a sample examination, and other necessary
supporting examination materials (e.g., answers, previous examination
statistics or other background examination information, if requested).
Approval will be based on an objective review of qualifications that
include a copy of the MRO applicant application form, documentation
that the continuing education courses are accredited by a professional
organization, and the delivery method and content of the examination.
Each approved MRO certification entity must resubmit their
qualifications for approval every two years. The Secretary shall
publish at least every two years a notice in the Federal Register
listing those entities and subspecialty boards that have been approved.
This notice is also available on the internet at https://www.samhsa.gov/workplace/drug-testing.''
HHS has completed its review of entities that certify MROs, in
accordance with requests submitted by such entities to HHS. The
Assistant Secretary for Mental Health and Substance Use approves the
following MRO certifying entities that offer MRO certification through
examination:
American Association of Medical Review Officers (AAMRO), P.O. Box
12873, Research Triangle Park, NC 27709, Phone: (919) 489-5407, Fax:
(919) 490-1010, Email: [email protected], Website: https://www.aamro.com/.
Medical Review Officer Certification Council (MROCC), 3231 S. Halsted
St, #167, Chicago, IL 60608, Phone: (847) 631-0599, Fax: (847) 483-
1282, Email: [email protected], Website: https://www.mrocc.org/.
MROPREP, 2108 N St, STE N, Sacramento, CA 95816, Phone: (669) 299-5348,
Email: [email protected], Website: https://www.mroprep.com/courses/mrocourse.
Miriam E. Delphin-Rittmon,
Assistant Secretary for Mental Health and Substance Use.
[FR Doc. 2022-17156 Filed 8-9-22; 8:45 am]
BILLING CODE 4162-20-P
